For the auspicious day of Yud Shevat, Sichos in English has made the English translation of the Frierdiker Rebbe’s Basi ...

Enfortumab vedotin (EV) with pembrolizumab (P) versus chemotherapy (chemo) in previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC): Analysis of the cisplatin ...

Praxis Management Group Inc. announces Georgia market expansion and continued growth driven by its strategic partnership with AT&T. Read on to find out more. SANDY ...

Fortnite's annual seasonal event is here, bringing Christmas to the battle royale with Winterfest 2025. Not only are there new skins and cosmetics, but half the Chapter 7 Season 1 map is now covered ...

We write about the best sales on the internet each day on the Strategist, but occasionally, we like to do some dealmaking of our own to secure extra-special discounts just for our readers. For the ...

There is no equivalent term in the toy industry to “fast fashion,” but there should be. The cost of producing toys has been on a long-term decline, making it easier than ever for parents in rich ...

Praxis Precision Medicines is converting its EMBRAVE3 study of elsunersen for children suffering from a developmental disease into a single-arm study after meeting with the Food and Drug ...

Having already claimed a win for the phase 2 study of its seizure drug, Praxis Precision Medicines is hoping fresh efficacy data will form the backbone of an approval application for the sodium ...

Praxis Precision Medicines has also announced a “successful” pre-NDA meeting with the FDA for its essential tremor drug candidate ulixacaltamide, for which an approval application is slated for early ...

Praxis confirms an upcoming meeting with the FDA to discuss the results and NDA path BOSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage ...